식도암에서 외부방사선치료와 근접방사선치료의 병용요법

남택근,나병식,오윤경 조선대학교 부설 의학연구소 2002 The Medical Journal of Chosun University Vol.27 No.2

Background and Objectives: To evaluate the role of brachytherapy following external radiotherapy by retrospective analysis in view of survival and prognostic factors in esophageal carcinoma. Materials and Methods: From Apr. 1999 to Dec. 2000, a total of 28 patients, who were diagnosed as esophageal carcinoma, were treated by curative external radiotherapy followed by brachytherapy with or without chemotherapy. Eligible primary tumors were located in the thoracic esophagus and lymphatic metastases were restricted to supraclavicular or mediastinal nodes. External radiotherapy was performed by 6 MV or 10 MV X-ray and the range of doses was 50.0 Gy - 59.4 Gy (median; 54.9) to primary tumors. One week later, the intraluminal brachtherapy (IB) was performed by high-dose rate remote controlled afterloader with radioisotope of ^192Ir. Fraction size of IB was 2~5 Gy, twice a week and delivered up to total doses of 3 Gy~ 20 Gy (median; 12). Twenty-one patients were treated by concurrent chemotherapy with the agents of cisplatin and 5-FU. Cisplatin, 75 ㎎/㎡, was given on the first day of weeks 1, 5, 8, 11 and 5-FU, 1,000 ㎎/㎡, was administered as a continuous infusion for the first 4 days of each course. Results: The estimated median survival time was 15 months and 1, 2, 3-year survival rates were 60.7%, 27.5%, 9.2%, respectively. The median survival time (MST) of the patients with stage II (n=9), III (n=17), IVA (n=2) were 20, 15, 5 months, respectively (p=0.68). The MST of the patients with complete response vs partial response were 21 vs 14 months, respectively (p=0.12). The MST of patients younger than 60 years vs older were 22 vs 12 months, respectively (p=0.07). The MST of patients with ECOG performance index 1 vs 2 were 16 vs 10 months, respectively (P=0.06) Tile Mn of patients treated by concurrent chemotherapy vs untreated were 20 vs 12 months, respectively (p=0.07). Four patients (14.3%) suffered massive hematemesis after brachytherapy and one patient with local recurrence salvaged by esophagectomy had mediastinal abscess. Of 21 patients treated by concurrent chemoradiothetapy, one patient had pancytopenia and other two patients had severe leukopenia. Conclusion: This study showed no better outcomes of brachytherapy boost after external radiotherapy than historical results of external radiotherapy alone. Concurrent chemotherapy might have more significant therapeutic role rather than brachytherapy boost and the employment of brachythelapy should be considered with great caution in the treatment of esophageal carcinoma.

전이성 뇌종양에 대한 고식적 방사선치료의 결과

고영삼,오윤경,남택근 조선대학교 2003 The Medical Journal of Chosun University Vol.28 No.1

Background and Obiectives : To evaluate the role of palliative radiotherapy in the treatment of metastatic brain tumor with respect to response, survival and prognostic factors, retrospectively Materials ðods : From Jan 1998 to Jan 2003, a total of 57 patients diagnosed as metastatic brain tumor were referred for palliative radiotherapy Of them, forty-four patients were eligible for this study. The most common primary tumor was lung cancer in 31 patients (70.5%). A total doses of 27.5-40.0 Gy were delivered to whole brain with daily doses of 2.0-3.0 Gy To evaluate the treatment response, all patients were evaluated by neurological functional classification prior to and after radiotherapy Results : The positive response was noted in 36 patients (81.8%) and 8 patients (18.2%) did not improve. The median survival time of all patients was 6 months. 1-and 2-year survival rates were 17.4% and 2.9%, respectively. The median survival time of patients younger than 60 vs older were 9 vs 4 months (p=0.009), respectively. The median survival time of patients with stable vs progressive vs unknown primary status were 9 vs 4 vs 5 months (p=0.003), respectively Multivariate analysis showed that age and primary tumor status were independently significant prognostic factors affecting survival. Conclusion : The radiotherapy could relieve neurological symptoms effectively and promptly in most patients and prolong survival of patients. The most significant factors affecting survival were age and primary tumor status, and therefore more definitive treatment modality including surgical resection or radiosurgery should be considered in the patients with favorable prognostic factors.

초소형 구조물의 부착 방지를 위한 새로운 자기 집합 물질에 대한 연구

김봉환,오창훈,전국진,정택동,변장웅,이윤식 경북대학교 센서기술연구소 1998 센서技術學術大會論文集 Vol.9 No.1

In order to achieve stiction-free polysilicon surfaces, we have suggested a new chemical grafting precursor and confirmed their excellent characteristics. When dichlorodimethylsilane(DDS, C_(2)H_(6)SiCl_(2)), a dialkyldichlorosilane widely used in silicon machining, have been used as a precursor, experimental results were clearly comparable to those of monoalkyltrichlorosilanes octadecyltrichlorosilane (OTS, C_(18)H_(37)SiCl_(3)) or 1H,1H,2H,2H-perfluorodecyltrichloro-silane (FDTS, C_(10)H_(4)F_(17)SiCl_(3)) in terms of stiction reduction. The polysilicon cantilevers were fabricated in the carefully controlled conditions and laser interferometer indicated that their residual stress gradient was 2 MPa/μm upward from the substrate. The SEM images of polysilicon cantilever beams with DDS coating are upward and no stiction is observed up to 2 mm in length.

방사선 치료를 받는 암 환자들의 사회적 지지와 삶의 질과의 관계

정주희,류소연,윤혜은,남택근,오윤경,안현옥,박계남,이영선 朝鮮大學校 附設 醫學硏究所 2002 The Medical Journal of Chosun University Vol.27 No.2

Objective : This study was performed to investigate the relationship between social support and quality of life among cancer patients receiving radiation therapy. Matehals and Methods : The data were collected from 98 patients, who were receiving radiation therapy at two university hospitals located in GwangUJu, used by structured questionnaire. For statistical analyses of the association between quality of life and various characteristics, data were analyzed using t-test, ANOVA, Pearson 's correlation, and multiple regression analysis. Results: 1. There were 56(57.1%) males and 42(42.9%) females. Age ranged from 21 to 82 years. The primary sites of cancer were gastrointestinal tract (24.5%), lung (23.5%), breast (21.4%), and head and neck (11.2%) in order. 2. The mean scores of social, family, and medical support were 4.30 0.58, 4.49 0.78, 4.11 0.65, respectively. The score of quality of life was 5.83 1.63 (range: 1.95 ~ 9.05). 3. An analysis of the association between several factors of patients and quality of life showed that the statistically significant factors were age, the presence of distant metastasis, family support, medical support and social support. 4. As a result of the multiple regression analysis, only social support was significant (β=0.932, P=0.02) with quality of life, but age and presence of distant metastasis were not significant. Conclusion : This suggests that quality of life in cancer patients could be improved by strengthening the social support which consists of family and medical support. Further study would be necessary to evaluate separately several aspects of quality of life among cancer patients.

위암세포주에서 Recombinant Human Interferon-r와 Adriamycin의 투여순서가 항암효과에 미치는 영향

홍원선,손영숙,김창민,강윤구,이춘택,김유철,임영혁,남현석,이진오,강태웅 大韓免疫學會 1993 大韓免疫學會誌 Vol.15 No.-

Numerous previous studies, both in vitro and in vivo, have demonstrated that the cytotoxicity can be enhanced by the combination of chemotherapeutic agent and interferons(IFNs) in various types of cancer cells. We have previously reported that combined treatment of MKN-45, human gastric adenocarcinoma cells, with adriamycin(ADM) and recombinant human interferon-r(rh-IFN-r) increased in the cytotoxicity. In this study, the effects of combination timing of rh-IFN-r and ADM on the cytotoxicity against MKN-45 were investigated using MTT assay. MKN-45 was treated with rh-IFN-r and ADM in vitro on three schedules : Treat A ; rh-IFN-r and ADM were treated simultaneously, Treat B ; rh-IFN-r was treated 24 hours after the treatment with ADM, Treat C ; rh-IFN-r was treated for 72 hours and followed by the treatment with ADM. The survival of MKN -45 was inhibited by ADM dose-dependently. 102 and 103U/ml of rh-IFN-r significantly inhibited the survival of MKN-45(% survival : 35.1 ±-1.2% and 34.4 ±1.1% in Treat A and 42.5 ± 2.1% and 45.9-±2.5% in Treat C, respectively). However no difference in the survival was observed between 102 and 103U/ml of rh-IFN-r. Combined treatment with rh-IFN-r and ADM significantly augmented the cytotoxicity at low concentrations of ADM. Combined effects of rh-IFN-r and ADM were evaluated using IC30(,ag/ml) to ADM. IC30s of MKN-45 in Treat A, B and C at 102 U/ml of rh -IFN-r _ were 0.019 -?- 0.003, 0.045 :I:0.001 and 0.054 ± 0.012, respectively, while IC30 of MKN-45 treated with ADM alone was 0.052±0.004. IC30s of MKN-45 in ADM alone group, Treat A, Treat B and Treat C at 103U/ml of rh-IFN-r were 0.047 ±0.003, 0.004 -±0.001, 0.031 ±0.004 and 0.056 0.008, respectively. These results indicate IC30s of Treat A and B were significantly lower than those of ADM alone(p<0.05) and IC30s of Treat A was significantly lower than those of Treat B(p <0.01). IC30s of Treat C, however, were not different from those of ADM alone. From these results demonstrating that cytotoxic effects were increased by the combination of rh-IFN-r and ADM in the order, Treat A > Treat B> Treat C, it can be concluded that the simultaneous administration of rh-IFN-r and ADM may be the most effective method to combine these two therapeutic modalties.

Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA

Oh, Taek-In,Lee, Yoon-Mi,Nam, Taek-Jin,Ko, Young-San,Mah, Shinmee,Kim, Jinhee,Kim, Younghoon,Reddy, Rallabandi Harikrishna,Kim, Young Jun,Hong, Sungwoo,Lim, Ji-Hong MDPI 2017 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Vol.18 No.10

<P>Fascaplysin has been reported to exert anti-cancer effects by inhibiting cyclin-dependent kinase 4 (CDK4); however, the precise mode of action by which fascaplysin suppresses tumor growth is not clear. Here, we found that fascaplysin has stronger anti-cancer effects than other CDK4 inhibitors, including PD0332991 and LY2835219, on lung cancer cells that are wild-type or null for retinoblastoma (RB), indicating that unknown target molecules might be involved in the inhibition of tumor growth by fascaplysin. Fascaplysin treatment significantly decreased tumor angiogenesis and increased cleaved-caspase-3 in xenografted tumor tissues. In addition, survivin and HIF-1α were downregulated in vitro and in vivo by suppressing 4EBP1-p70S6K1 axis-mediated de novo protein synthesis. Kinase screening assays and drug-protein docking simulation studies demonstrated that fascaplysin strongly inhibited vascular endothelial growth factor receptor 2 (VEGFR2) and tropomyosin-related kinase A (TRKA) via DFG-out non-competitive inhibition. Overall, these results suggest that fascaplysin inhibits TRKA and VEGFR2 and downregulates survivin and HIF-1α, resulting in suppression of tumor growth. Fascaplysin, therefore, represents a potential therapeutic approach for the treatment of multiple types of solid cancer.</P>

A2B Adenosine Receptor Stimulation Down-regulates M-CSF-mediated Osteoclast Proliferation

Yoon Taek Oh,Na Kyung Lee 대한의생명과학회 2017 Biomedical Science Letters Vol.23 No.3

Bone-resorbing osteoclasts play a major role in maintaining bone homeostasis with bone-forming osteoblasts. Although it has been reported that A2B adenosine receptor (A2BAR) regulates osteoclast differentiation, its effects on apoptosis or proliferation of osteoclasts have been less-defined. Here, we demonstrate that A2BAR stimulation regulates macrophage-colony stimulating factor (M-CSF)-mediated osteoclast proliferation. Stimulation with a specific agonist of A2BAR, BAY 60-6583, significantly reduced M-CSF-mediated osteoclast proliferation in a time- and dose-dependent manner. In addition, A2BAR stimulation induced both apoptosis of the cells and cell arrest in the G1 phase with a decrease of cell number in the G2/M phase. Stimulation with BAY 60-6583 inhibited the activation of Akt by M-CSF, whereas M-CSF-induced ERK1/2 activation was not affected. These results suggest that the inhibition of M-CSF-mediated Akt activation by A2BAR stimulation increases apoptotic response of osteoclasts and induces cell cycle arrest in the G1 phase, thus contributing to the down-regulation of osteoclast proliferation.

Cholera Toxin Production during Anaerobic Trimethylamine <i>N</i>-Oxide Respiration Is Mediated by Stringent Response in <i>Vibrio cholerae</i>

Oh, Young Taek,Park, Yongjin,Yoon, Mi Young,Bari, Wasimul,Go, Junhyeok,Min, Kyung Bae,Raskin, David M.,Lee, Kang-Mu,Yoon, Sang Sun American Society for Biochemistry and Molecular Bi 2014 The Journal of biological chemistry Vol.289 No.19

<P>As a facultative anaerobe, <I>Vibrio cholerae</I> can grow by anaerobic respiration. Production of cholera toxin (CT), a major virulence factor of <I>V. cholerae</I>, is highly promoted during anaerobic growth using trimethylamine <I>N</I>-oxide (TMAO) as an alternative electron acceptor. Here, we investigated the molecular mechanisms of TMAO-stimulated CT production and uncovered the crucial involvement of stringent response in this process. <I>V. cholerae</I> 7th pandemic strain N16961 produced a significantly elevated level of ppGpp, the bacterial stringent response alarmone, during anaerobic TMAO respiration. Bacterial viability was impaired, and DNA replication was also affected under the same growth condition, further suggesting that stringent response is induced. A Δ<I>relA</I> Δ<I>spoT</I> ppGpp overproducer strain produced an enhanced level of CT, whereas anaerobic growth via TMAO respiration was severely inhibited. In contrast, a ppGpp-null strain (Δ<I>relA</I> Δ<I>spoT</I> Δ<I>relV</I>) grew substantially better, but produced no CT, suggesting that CT production and bacterial growth are inversely regulated in response to ppGpp accumulation. Bacterial capability to produce CT was completely lost when the <I>dksA</I> gene, which encodes a protein that works cooperatively with ppGpp, was deleted. In the Δ<I>dksA</I> mutant, stringent response growth inhibition was alleviated, further supporting the inverse regulation of CT production and anaerobic growth. <I>In vivo</I> virulence of Δ<I>relA</I> Δ<I>spoT</I> Δ<I>relV</I> or Δ<I>dksA</I> mutants was significantly attenuated. The Δ<I>relA</I> Δ<I>spoT</I> mutant maintained virulence when infected with exogenous TMAO despite its defective growth. Together, our results reveal that stringent response is activated under TMAO-stimulated anaerobic growth, and it regulates CT production in a growth-dependent manner in <I>V. cholerae</I>.</P>

정삼투 공정을 이용한 미량유해물질 제거효율 평가

오윤택 ( Yoon Taek Oh ),유영범 ( Young Beom Yoo ),이준석 ( Jun Seok Lee ),이상엽 ( Sang Youp Lee ),홍승관 ( Seung Kwan Hong ) 한국물환경학회(구 한국수질보전학회) 2011 한국물환경학회·대한상하수도학회 공동 춘계학술발표회 Vol.2011 No.-

Cardiovascular Biology and Diseases : TotalPlex gene amplification with bulging primers for SNP analysis of hypertension related Loci

( Yong Taek Oh ),( So Yeon Yoon ),( Mi So Chae ),( Bong Kyu Kim ),( Jong Keun Park ),( Sung Joo ),( Yoon Kim ),( Byoung Don Han ) 한국생화학분자생물학회 (구 한국생화학회) 2008 생화학분자생물학회 춘계학술발표논문집 Vol.2008 No.-